Axogen (AXGN) Non-Current Debt (2011 - 2025)
Axogen (AXGN) recorded quarterly Non-Current Debt of $48.4 million in Q4 2025, little changed quarter-over-quarter from $48.2 million in Q3 2025, and up 1.88% on a YoY basis from $47.5 million in Q4 2024.
Axogen (AXGN) Non-Current Debt (2011 - 2025) Analysis & Trends
Axogen's Non-Current Debt history runs 15 years deep, the most recent figure standing at $48.4 million for Q4 2025.
- In Q4 2025, Non-Current Debt rose 1.88% year-over-year to $48.4 million; the TTM figure through Dec 2025 stood at $48.4 million (up 1.88% YoY), while the FY2025 annual figure was $48.4 million, up 1.88% from the prior year.
- Non-Current Debt was $48.4 million for Q4 2025 at Axogen, roughly flat from $48.2 million in the prior quarter.
- In the past five years, Non-Current Debt ranged from a high of $48.4 million in Q4 2025 to a low of $32.1 million in Q1 2021.
- Historically, Non-Current Debt has averaged $45.8 million across 5 years, with a median of $46.3 million in 2021.
- The sharpest annual moves came in 2021 and 2022: Non-Current Debt surged 2603.11% in 2021, then retreated 1.78% in 2022.
- A 5-year view of Non-Current Debt shows it stood at $44.8 million in 2021, then grew by 1.99% to $45.7 million in 2022, then grew by 1.95% to $46.6 million in 2023, then advanced by 1.92% to $47.5 million in 2024, then grew by 1.88% to $48.4 million in 2025.
- The last three Non-Current Debt figures came in at $48.4 million (Q4 2025), $48.2 million (Q3 2025), and $47.9 million (Q2 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non-Current Debt (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 154.42 Bn | 147.76 Bn | 6.27 Bn | 29.64 Bn |
| 2 | Stryker | 118.12 Bn | 115.25 Bn | 3.81 Bn | 14.22 Bn |
| 3 | Medtronic | 101.72 Bn | 93.55 Bn | 5.76 Bn | 27.88 Bn |
| 4 | Boston Scientific | 67.19 Bn | 65.98 Bn | 3.61 Bn | 10.99 Bn |
| 5 | Edwards Lifesciences | 50.69 Bn | 47.02 Bn | 1.29 Bn | 598.50 Mn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | 8.07 Bn |
| 7 | Dexcom | 28.09 Bn | 26.97 Bn | 750.30 Mn | - |
| 8 | GE HealthCare Technologies | 28.08 Bn | 26.02 Bn | 1.98 Bn | 10.13 Bn |
| 9 | Steris | 19.80 Bn | 19.37 Bn | 697.10 Mn | 1.81 Bn |
| 10 | Axogen | 2.32 Bn | 2.22 Bn | 46.19 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 48.39 Mn |
| Dec 31, 2025 | 48.39 Mn |
| Sep 30, 2025 | 48.16 Mn |
| Sep 30, 2025 | 48.16 Mn |
| Jun 30, 2025 | 47.94 Mn |
| Jun 30, 2025 | 47.94 Mn |
| Mar 31, 2025 | 47.72 Mn |
| Mar 31, 2025 | 47.72 Mn |
| Dec 31, 2024 | 47.50 Mn |
| Dec 31, 2024 | 47.50 Mn |
| Sep 30, 2024 | 47.27 Mn |
| Sep 30, 2024 | 47.27 Mn |
| Jun 30, 2024 | 47.05 Mn |
| Jun 30, 2024 | 47.05 Mn |
| Mar 31, 2024 | 46.83 Mn |
| Mar 31, 2024 | 46.83 Mn |
| Dec 31, 2023 | 46.60 Mn |
| Dec 31, 2023 | 46.60 Mn |
| Sep 30, 2023 | 46.38 Mn |
| Sep 30, 2023 | 46.38 Mn |